Beacon Pharmaceuticals PLC, a publicly listed company in the pharmaceuticals and chemicals sector, has announced its dividend for the financial year ending June 30, 2025. For the discussed year, the company will distribute a 21% cash dividend to its general shareholders. However, the sponsor-shareholders and directors will not receive any dividend.
The decision was made at the company’s board meeting held on Wednesday (October 22), following the review and approval of the audited financial statements for the latest fiscal year, according to company sources.
According to those sources, the company earned Tk 4.10 per share in the last financial year, compared to Tk 2.26 per share in the previous year.
Last year, Beacon’s cash flow per share stood at Tk 6.93, up from a negative Tk 0.78 in the prior year. As of June 30, 2025, the company’s net asset value per share (NAVPS) was Tk 28.86.
The company’s Annual General Meeting (AGM) will be held on December 23 at 11:00 a.m. through a hybrid (both physical and virtual) system. The record date for the AGM has been set for November 10.
